Heart surgery sugar showdown: which blood sugar target saves lives?
NCT ID NCT07485101
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test two ways of controlling blood sugar during heart surgery in 3000 elderly patients with type 2 diabetes. One group will have tight control (blood sugar between 5-8 mmol/L) and the other liberal control (11-14 mmol/L). The goal is to see which approach leads to fewer major complications like death, kidney injury, heart attack, or stroke.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Insulin
- What this could lead to
- If it works, this could point toward a safer way to manage blood sugar during heart surgery for elderly diabetics, reducing the risk of major complications like kidney injury or stroke.
- What could go wrong
- This trial hasn't started yet, and it's comparing two existing strategies rather than testing a new drug. The results may not apply to younger patients or those without diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLYCEMIC MANAGEMENT DURING CPB IN ELDERLY DIABETIC CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?